scholarly article | Q13442814 |
P356 | DOI | 10.1097/CRD.0000000000000013 |
P698 | PubMed publication ID | 24407048 |
P50 | author | William H. Frishman | Q100303887 |
P2093 | author name string | Elliot Coburn | |
P433 | issue | 4 | |
P304 | page(s) | 171-175 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Cardiology in Review | Q5038711 |
P1476 | title | Comprehensive review of the prognostic value of galectin-3 in heart failure | |
P478 | volume | 22 |
Q91640383 | Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction |
Q41736786 | Can be galectin-3 a novel marker in determining mortality in hemodialysis patients? |
Q40898595 | Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis |
Q90437159 | Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction |
Q90152813 | Galectin-3 Is a Potential Mediator for Atherosclerosis |
Q38269044 | Heart failure and galectin 3. |
Q40491689 | Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis |
Q36757833 | Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure |
Q38225729 | Review of the prognostic value of galectin-3 in heart failure focusing on clinical utility of repeated testing |
Q38743657 | The role of cardiac biochemical markers in aortic stenosis. |
Search more.